BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 32879955)

  • 1. Commentary: Could microchimerism play a role in ovarian carcinogenesis?
    Lee AW
    Int J Epidemiol; 2021 Mar; 50(1):95-96. PubMed ID: 32879955
    [No Abstract]   [Full Text] [Related]  

  • 2. Male origin microchimerism and ovarian cancer.
    Hallum S; Jakobsen MA; Gerds TA; Pinborg A; Tjønneland A; Kamper-Jørgensen M
    Int J Epidemiol; 2021 Mar; 50(1):87-94. PubMed ID: 32065627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian Clear Cell Carcinoma: From Morphology to Molecular Biology.
    Improta G; Pettinato A; Høgdall E; Santeusanio G; Vatrano S; Fraggetta F; Zannoni GF
    Appl Immunohistochem Mol Morphol; 2019 Oct; 27(9):631-636. PubMed ID: 29629954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling Epithelial Ovarian Cancer in Mice: Classical and Emerging Approaches.
    Zakarya R; Howell VM; Colvin EK
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32645943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-reducing salpingectomy as a new and safe strategy to prevent ovarian cancer.
    Morelli M; Venturella R; Zullo F
    Am J Obstet Gynecol; 2013 Oct; 209(4):395-6. PubMed ID: 23665245
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the long non-coding RNA TDRG1 in epithelial ovarian carcinoma tumorigenesis and progression through miR-93/RhoC pathway.
    Chen S; Wang LL; Sun KX; Xiu YL; Zong ZH; Chen X; Zhao Y
    Mol Carcinog; 2018 Feb; 57(2):225-234. PubMed ID: 28984384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma.
    Chen S; Wu DD; Sang XB; Wang LL; Zong ZH; Sun KX; Liu BL; Zhao Y
    Cell Death Dis; 2017 Oct; 8(10):e3118. PubMed ID: 29022892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply: To PMID 23583217.
    Erickson BK; Landen CN; Conner MG
    Am J Obstet Gynecol; 2013 Oct; 209(4):396. PubMed ID: 23665249
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of the REG4 gene and its encoding product in ovarian epithelial carcinoma.
    Chen S; Gou WF; Zhao S; Niu ZF; Zhao Y; Takano Y; Zheng HC
    BMC Cancer; 2015 Jun; 15():471. PubMed ID: 26077911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model.
    Mehdi S; Macdonald E; Galpin K; Landry DA; Rodriguez G; Vanderhyden B; Bachvarov D
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
    Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
    Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of DPP9 in gene fusions in serous ovarian carcinoma.
    Smebye ML; Agostini A; Johannessen B; Thorsen J; Davidson B; Tropé CG; Heim S; Skotheim RI; Micci F
    BMC Cancer; 2017 Sep; 17(1):642. PubMed ID: 28893231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting HSF1 leads to an antitumor effect in human epithelial ovarian cancer.
    Chen YF; Wang SY; Yang YH; Zheng J; Liu T; Wang L
    Int J Mol Med; 2017 Jun; 39(6):1564-1570. PubMed ID: 28487934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcription factor FOXA1 induces epithelial ovarian cancer tumorigenesis and progression.
    Wang LL; Xiu YL; Chen X; Sun KX; Chen S; Wu DD; Liu BL; Zhao Y
    Tumour Biol; 2017 May; 39(5):1010428317706210. PubMed ID: 28488543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal regulation of beta-catenin during development of the avian oviduct and its expression in epithelial cell-derived ovarian carcinogenesis.
    Bae SM; Lim W; Jeong W; Lee JY; Kim J; Han JY; Bazer FW; Song G
    Mol Cell Endocrinol; 2014 Jan; 382(1):46-54. PubMed ID: 24055276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG8 induces ovarian carcinoma cells cellular process and stemness through Wnt/β-catenin pathway.
    Miao W; Lu T; Liu X; Yin W; Zhang H
    Cancer Biomark; 2020; 28(4):459-471. PubMed ID: 32538821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LINC00858 aggravates the oncogenic phenotypes of ovarian cancer cells through miR-134-5p/RAD18 signaling.
    Xue H; Wu Z; Rao D; Zhuo B; Chen Q
    Arch Gynecol Obstet; 2020 Nov; 302(5):1243-1254. PubMed ID: 32875345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt11 alters integrin and cadherin expression by ovarian cancer spheroids and inhibits tumorigenesis and metastasis.
    Azimian-Zavareh V; Hossein G; Ebrahimi M; Dehghani-Ghobadi Z
    Exp Cell Res; 2018 Aug; 369(1):90-104. PubMed ID: 29753625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling.
    Huang CC; Cheng SH; Wu CH; Li WY; Wang JS; Kung ML; Chu TH; Huang ST; Feng CT; Huang SC; Tai MH
    Oncogene; 2019 Apr; 38(17):3201-3215. PubMed ID: 30626939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.
    Wang J; Ding W; Xu Y; Tao E; Mo M; Xu W; Cai X; Chen X; Yuan J; Wu X
    Aging (Albany NY); 2020 Mar; 12(5):4558-4572. PubMed ID: 32163372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.